A practical approach to Design of Experiments for downstream processing of antibody fragments, by Mr Klaus Kaiser, #Bayer Healthcare

Speaking on the above topic is Mr Klaus Kaiser, Head GMP Purification Global / Global Biological Development, Bayer Healthcare LLC, United States. He will be presenting at Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore. Mr Kaiser received his Ph.D. …

Roche Pharmaceuticals produce next generation therapeutic antibodies using today’s cell-culture technology

Roche Pharmaceuticals produce next generation therapeutic antibodies using today's cell-culture technology: Are you looking to deliver next generation therapeutic antibodies using existing cell culture technology? Do you want to reduce costs by utilising existing bio-manufacturing methodologies? Find out how this goal was achieved at the Cell Culture World Congress 2012 where Dr Ingo Gorr, Senior Research Scientist Cell Culture Research …